🇺🇸 FDA

Intelligence Platform

Patents

Browse 252 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9845332

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840460

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9839639

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828367

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783507

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9771337

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765028

Crystalline freebase forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC · Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9725470

Substituted naphthyridines as JAK kinase inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9725448

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9724359

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9688692

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9688616

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9683002

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682052

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675599

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9669027

Hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670143

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methyl

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670186

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670140

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663509

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9656993

Crystalline forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9630960

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

Theravance Biopharma R&D IP, LLC · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9593110

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9585882

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted